SEC Form 4 · accession 0001179110-15-002166
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick E Winningham
Officer — Chief Executive Officer · Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 5, 2015 | A | 250,000 | $0.00 | A | 521,581 | D | |
| Ordinary Shares | Aug 20, 2014 | W | 57 | $0.00 | A | 521,638 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 271,581 shares acquired in a pro rata distribution by Theravance, Inc., 39,685 of which relate to a performance stock award granted by Theravance, Inc. on February 11, 2011 for which the performance conditions were achieved on February 5, 2015 (and which will vest on February 20, 2016, subject to the reporting person's continued employment through such date).